The 'go to' European specialist pharma company
Sterculia 62% and Frangula bark 8%
Licensed in the UK for the treatment of constipation, particularly hypertonic or slow transit constipation, resistant to bulk alone. The initiation and maintenance of bowel action after rectal surgery and after haemorrhoidectomy
The links below will redirect you to an alternative site not maintained by Norgine Pharmaceuticals Limited
View the Patient Information Leaflet
View the Summary of Product Characterisitics
Please consult with your Doctor, or other qualified Healthcare Professional before use.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.